Are RA and PsA linked to heart or lung problems? 

While Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PsA) are primarily known for causing joint pain, they are systemic autoimmune conditions. This means the overactive immune system doesn’t just target the joints; it can also affect vital organs, most notably the heart and lungs. In the UK, modern rheumatology care involves more than just joint management; it includes a comprehensive approach to cardiovascular and respiratory health. Understanding these links is essential for long-term wellbeing and effective disease management. 

What We’ll Discuss in This Article 

• The link between chronic inflammation and cardiovascular disease 

• How RA and PsA can cause Interstitial Lung Disease (ILD) 

• The impact of systemic inflammation on blood vessels (Vasculitis) 

• Screening and monitoring for heart and lung health in the UK 

• The role of medication in reducing systemic risks 

• Lifestyle changes to protect your heart and lungs alongside arthritis care 

Both RA and PsA are linked to an increased risk of heart and lung problems because the same inflammatory proteins that damage the joints can also cause inflammation in the lining of the lungs and the walls of the arteries. The NHS emphasizes that because these conditions are systemic, regular check-ups for blood pressure, cholesterol, and lung function are a standard part of long-term arthritis care to identify and manage these risks early. 

The Heart: Inflammation and Cardiovascular Risk 

People with RA and PsA have a statistically higher risk of developing cardiovascular disease compared to the general population. This is not necessarily because of the joints themselves, but because chronic, systemic inflammation accelerates atherosclerosis, the buildup of plaque in the arteries. 

Arterial Stiffness

Persistent inflammation can make blood vessels less flexible, leading to higher blood pressure.

Pericarditis

Inflammation of the sac surrounding the heart (the pericardium), which can cause chest pain.

Heart Valve Issues

In rare cases, chronic inflammation can cause scarring or thickening of the heart valves.

The British Heart Foundation and Versus Arthritis both note that managing your arthritis effectively with Disease-Modifying Anti-Rheumatic Drugs (DMARDs) or biologics actually helps protect your heart by lowering the overall “inflammatory load” in your body. In the UK, your rheumatology team or GP will likely conduct a cardiovascular risk assessment (such as a QRISK score) as part of your annual review. 

The Lungs: Inflammation and Scarring 

The lungs are rich in connective tissue, making them a potential target for the immune system in both RA and PsA. The most significant concern is Interstitial Lung Disease (ILD), where the lung tissue becomes inflamed and eventually scarred (fibrosis), making it harder for oxygen to enter the bloodstream. 

Rheumatoid Nodules

Small, non-cancerous lumps that can form in the lungs of people with RA.

Pleurisy

Inflammation of the lining of the lungs, which causes sharp pain when breathing in.

Bronchiectasis

Damage to the airways that makes it harder to clear mucus, increasing the risk of infections.

According to the British Lung Foundation, early signs of lung involvement include a persistent dry cough or feeling breathless during activities that used to be easy. If you experience these symptoms, your consultant may arrange for a high-resolution CT scan or lung function tests to check for early signs of inflammation. 

Comparison of Systemic Risks: RA vs. PsA 

Organ System	Rheumatoid Arthritis (RA)	Psoriatic Arthritis (PsA)
Heart Risk	High; linked to systemic cytokines	Increased; often linked to metabolic syndrome
Lung Risk	Higher risk of ILD and nodules	Lower risk of ILD but increased airway issues
Vessels	Potential for Vasculitis (inflamed vessels)	Linked to higher rates of hypertension
Prevention	Aggressive inflammation control	Weight management and inflammation control

Protecting Your Vital Organs 

The most effective way to protect your heart and lungs is to achieve “clinical remission” of your arthritis. When the joint inflammation is quiet, the systemic inflammation is also reduced. 

In addition to your prescribed medication, UK clinical guidelines recommend: 

Smoking Cessation

Smoking is the single biggest risk factor for lung disease in RA and significantly increases cardiovascular risk.

Monitoring Vitals

Regular checks for blood pressure, glucose levels, and cholesterol.

Cardiovascular Exercise

Low-impact movement like swimming or cycling supports heart health without jarring the joints.

Vaccinations

Staying up to date with flu and pneumonia vaccines to protect vulnerable lung tissue.

Conclusion 

RA and PsA are whole-body conditions, and their link to heart and lung health is a serious consideration. However, this risk is manageable. Through a combination of early treatment to control inflammation and proactive lifestyle choices, the vast majority of people can protect their vital organs. If you experience sudden chest pain, severe shortness of breath, or a persistent new cough, call 999 or seek urgent medical attention immediately. 

Authority Snapshot (E-E-A-T Block) 

This guide provides evidence-based information on the systemic effects of RA and PsA, adhering to clinical standards from the NHS, NICE, and the British Society for Rheumatology. The content is authored by the Medical Content Team and reviewed by Dr. Rebecca Fernandez, a UK-trained physician with experience in internal medicine and emergency care. Our goal is to provide safe, factual, and practical information to help the public manage the long-term health implications of autoimmune conditions.